Acceptance of recommendations by inpatient pharmacy case managers: unintended consequences of hospitalist and specialist care.

Abstract:

STUDY OBJECTIVE:To determine whether recommendations made by pharmacists and accepted by hospital physicians resulted in fewer postdischarge readmissions and urgent care visits compared with recommendations that were not implemented. DESIGN:Prospective substudy of pharmacist recommendations. SETTING:Tertiary care academic medical center and private community-based physician practices and community pharmacies. PATIENTS:A total of 192 patients aged 18 years or older who were a subsample of a randomized, prospective study, who were admitted with a previous diagnosis of one of nine cardiovascular or pulmonary diseases or diabetes mellitus or had received oral anticoagulation therapy and who were discharged to community-based care provided by private physicians and community pharmacists. MEASUREMENTS AND MAIN RESULTS:Pharmacy case managers performed evaluations for patients and made recommendations to inpatient physicians. Patients received drug therapy counseling, a drug therapy list, and a wallet card at discharge. Data were collected from patients and private physicians for 90 days after discharge. Pharmacy case managers made 546 recommendations to inpatient physicians for 187 patients (97%). Overall, 260 (48%) of the 546 recommendations were accepted. The acceptance rate was lower for patients who had an urgent care visit compared with the other patients (33.6% vs 52.2%, p=0.033). High acceptance rates were noted for updating the record after medication reconciliation (36 patients [78%]) and when there was an actual allergy (2 [100%] of 2 patients) or medication error (2 [100%] of 2 patients). Physicians were less likely to accept recommendations related to drug indications (p<0.001), drug efficacy (p=0.041), and therapeutic drug and disease state monitoring (p=0.011). Recommendations made for patients with a relatively greater number of drugs were also less likely to be accepted (p=0.003). CONCLUSION:Recommendations to reconcile medications or address actual drug allergies or medication errors were frequently accepted. However, only 48% of all recommendations were accepted by inpatient physicians, and there was no impact on health care use 90 days after discharge. This study suggests that recommendations by pharmacy case managers were underused, and the low acceptance rate may have reduced the potential to avoid readmissions.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Anderegg SV,Demik DE,Carter BL,Dawson JD,Farris K,Shelsky C,Kaboli P

doi

10.1002/phar.1164

subject

Has Abstract

pub_date

2013-01-01 00:00:00

pages

11-21

issue

1

eissn

0277-0008

issn

1875-9114

journal_volume

33

pub_type

杂志文章
  • Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.

    abstract:STUDY OBJECTIVE:To assess the influence of withholding continuous enteral nutrition for 1 hour before and after warfarin administration compared with the coadministration of warfarin with continuous enteral nutrition on changes in international normalized ratios (INRs). DESIGN:Retrospective, crossover case series. SE...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.3.308

    authors: Dickerson RN,Garmon WM,Kuhl DA,Minard G,Brown RO

    更新日期:2008-03-01 00:00:00

  • Therapeutic drug monitoring of continuous-infusion acylovir for disseminated herpes simplex virus infection in a neonate receiving concurrent extracorporeal life support and continuous renal replacement therapy.

    abstract::Disseminated herpes simplex virus (HSV) infection in neonates represents a devastating entity that yields high mortality. Acyclovir is the primary antiviral agent used to treat life-threatening HSV infections in neonates; however, even though the agent has reduced morbidity overall from these infections, mortality wit...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1526

    authors: Cies JJ,Moore WS 2nd,Miller K,Small C,Carella D,Conley S,Parker J,Shea P,Chopra A

    更新日期:2015-02-01 00:00:00

  • Fluconazole-induced agranulocytosis with eosinophilia.

    abstract::Fluconazole is a commonly prescribed antifungal agent with a favorable safety profile. A patient experienced agranulocytosis and eosinophilia associated with the drug. Similar bone marrow-suppressive effect due to the azoles is rarely described in the English-language literature. ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.5.484.35058

    authors: Wong-Beringer A,Shriner K

    更新日期:2000-04-01 00:00:00

  • Tacrolimus toxicity associated with concomitant metoclopramide therapy.

    abstract::Subtherapeutic tacrolimus trough concentrations were noted in a 52-year-old woman who had undergone liver transplantation. Her tacrolimus dosage was increased from 7 to 28 mg twice/day, and ketoconazole therapy was added; however, her tacrolimus concentration remained undetectable. Metoclopramide 10 mg 4 times/day was...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.5.532.33357

    authors: Prescott WA Jr,Callahan BL,Park JM

    更新日期:2004-04-01 00:00:00

  • Current options in antifungal pharmacotherapy.

    abstract::Infections caused by yeasts and molds continue to be associated with high rates of morbidity and mortality in both immunocompromised and immunocompetent patients. Many antifungal drugs have been developed over the past 15 years to aid in the management of these infections. However, treatment is still not optimal, as t...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.28.5.614

    authors: Mohr J,Johnson M,Cooper T,Lewis JS,Ostrosky-Zeichner L

    更新日期:2008-05-01 00:00:00

  • Acute ischemic stroke update.

    abstract::Stroke is the third most common cause of death in the United States and is the number one cause of long-term disability. Legislative mandates, largely the result of the American Heart Association, American Stroke Association, and Brain Attack Coalition working cooperatively, have resulted in nationwide standardization...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.30.5.493

    authors: Baldwin K,Orr S,Briand M,Piazza C,Veydt A,McCoy S

    更新日期:2010-05-01 00:00:00

  • 1995 National Clinical Pharmacy Services Study.

    abstract::To determine the extent of hospital-based clinical pharmacy services in 1995, we surveyed 1109 United States acute care, general, medical-surgical, and pediatric hospitals with 50 or more licensed beds. Fifteen clinical pharmacy services were assessed to determine pharmacists' specific patient care responsibilities. T...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Raehl CL,Bond CA,Pitterle ME

    更新日期:1998-03-01 00:00:00

  • Pharmacodynamics of trimethoprim-sulfamethoxazole in Listeria meningitis: a case report.

    abstract::Infections in the cerebrospinal fluid (CSF) occur in an area of impaired host defenses; therefore, bactericidal antibiotics that reach adequate concentrations in the CSF are necessary for treatment. Measurements of antibiotic penetration into the CSF include CSF inhibitory and bactericidal titers, the absolute antibio...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Friedrich LV,White RL,Reboli AC

    更新日期:1990-01-01 00:00:00

  • Cabozantinib: A Multitargeted Oral Tyrosine Kinase Inhibitor.

    abstract::Cabozantinib is an oral small-molecule multitargeted tyrosine kinase inhibitor (TKI) that may confer an advantage over other TKIs that target a single receptor. It was approved by the U.S. Food and Drug Administration for the treatment of both advanced renal cell carcinoma and progressive metastatic medullary thyroid ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2076

    authors: Markowitz JN,Fancher KM

    更新日期:2018-03-01 00:00:00

  • Drug-Induced Ototoxicity: A Comprehensive Review and Reference Guide.

    abstract:OBJECTIVE:In an era of increasing polypharmacy, adverse drug effects such as ototoxicity have significant public health implications. Despite the availability of evidence, many health care professionals may not know the risk of ototoxicity in common medications. Therefore, the aim of this review is to provide a compreh...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2478

    authors: Rizk HG,Lee JA,Liu YF,Endriukaitis L,Isaac JL,Bullington WM

    更新日期:2020-12-01 00:00:00

  • Developing drug use evaluation criteria for parenteral fluoroquinolones.

    abstract::The basic tenet of pharmaceutical care asserts that the delivery of optimal, cost-effective pharmacotherapy can be best achieved by identifying, resolving, and preventing drug-related problems. Drug use evaluation (DUE) is one of the primary tools used to achieve these ends. Fluoroquinolone antimicrobials meet Joint C...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Guay DR,Covington TR,Alexander VL

    更新日期:1993-03-01 00:00:00

  • Sublingual administration of tacrolimus: current trends and available evidence.

    abstract::Widespread anecdotal use of sublingual tacrolimus administration has arisen, although little literature exists to guide practice. Given the paucity of data, we conducted a survey to evaluate the practice of sublingual tacrolimus administration at transplant centers across the United States and evaluated the literature...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1492

    authors: Doligalski CT,Liu EC,Sammons CM,Silverman A,Logan AT

    更新日期:2014-11-01 00:00:00

  • The future of cell therapy.

    abstract::Peripheral blood has replaced bone marrow as a source of hematopoietic stem cells for autologous rescue after high-dose chemotherapy. Patients who receive peripheral blood stem cell (PBSC) transplants experience rapid and sustained hematopoietic reconstitution. As a result, transplant-related mortality is now less tha...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Yee GC

    更新日期:1996-05-01 00:00:00

  • Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?

    abstract::The era of the integrase strand transfer inhibitors (INSTIs) for the treatment of human immunodeficiency virus (HIV) infection began with raltegravir in 2007. Since that time, several other INSTIs have been introduced including elvitegravir, dolutegravir, and, most recently, bictegravir, that have shown great utility ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2246

    authors: Brooks KM,Sherman EM,Egelund EF,Brotherton A,Durham S,Badowski ME,Cluck DB

    更新日期:2019-05-01 00:00:00

  • Evaluation of a Once/Day Tobramycin Regimen to Achieve Target Concentrations in Adult Patients with Cystic Fibrosis.

    abstract:STUDY OBJECTIVE:To evaluate the success of an initial tobramycin dosing regimen to achieve target peak and trough concentrations in adult patients with pulmonary exacerbations of cystic fibrosis (CF). DESIGN:Retrospective single-center medical record review. SETTING:Large tertiary care academic medical center. PATIE...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1762

    authors: Staubes BA,Metzger NL,Walker SD,Peasah SK

    更新日期:2016-06-01 00:00:00

  • Physician-pharmacist collaborative management of asthma in primary care.

    abstract:OBJECTIVE:To determine if asthma control improves in patients who receive physician-pharmacist collaborative management (PPCM) during visits to primary care medical offices. DESIGN:Prospective pre-post study of patients who received the intervention in primary care offices for 9 months. The primary outcome was the sum...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/phar.1468

    authors: Gums TH,Carter BL,Milavetz G,Buys L,Rosenkrans K,Uribe L,Coffey C,MacLaughlin EJ,Young RB,Ables AZ,Patel-Shori N,Wisniewski A

    更新日期:2014-10-01 00:00:00

  • Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.

    abstract:STUDY OBJECTIVE:To determine the effects of low-dose pioglitazone on plasma adipocyte-derived cytokines, high-sensitivity C-reactive protein (hs-CRP), and components of the metabolic syndrome in adults with the metabolic syndrome without diabetes mellitus. DESIGN:Prospective, randomized, double-blind, placebo-controll...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/phar.1713

    authors: Vu A,Kosmiski LA,Beitelshees AL,Prigeon R,Sidhom MS,Bredbeck B,Predhomme J,Deininger KM,Aquilante CL

    更新日期:2016-03-01 00:00:00

  • Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.

    abstract::Intravenous unfractionated heparin (UFH) remains an important therapeutic agent, particularly in the inpatient setting, for anticoagulation. Historically, the activated partial thromboplastin time (aPTT) has been the primary laboratory test used to monitor and adjust UFH. The aPTT test has evolved since the 1950s, and...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.2011.01049.x

    authors: Vandiver JW,Vondracek TG

    更新日期:2012-06-01 00:00:00

  • Respiratory tract penetration of quinolone antimicrobials: a case in study.

    abstract::Antimicrobial lung penetration is thought to be predictive of efficacy in the treatment of lower respiratory tract infections. Lung penetration studies are commonly conducted with new antimicrobial agents to elucidate their potential utility in treating such infections. Although some very useful information may emerge...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Ritrovato CA,Deeter RG

    更新日期:1991-01-01 00:00:00

  • Expanding Opportunities in the Postacute Long-Term Care Setting: Bringing Medication Safety to the Next Level.

    abstract::Skilled nursing facilities and nursing homes are care settings that offer increasing opportunities for pharmacists to take the lead when addressing the new updated Centers for Medicare and Medicaid Services (CMS) requirements coupled with enhanced quality measures reporting. In addition, the complexity of the medicati...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2155

    authors: Brandt NJ,Worz C,Clackum SF

    更新日期:2018-08-01 00:00:00

  • Pharmacologic and pharmacokinetic comparison of antianginal agents.

    abstract::Calcium channel blockers, nitrates, and beta blockers are the primary agents used for the treatment of angina. Calcium has a central role in excitation-contraction, action potential generation, and ischemic cell death. The three currently available calcium antagonists are nifedipine, verapamil, and diltiazem. Second-g...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1987.tb04052.x

    authors: Angaran D

    更新日期:1987-01-01 00:00:00

  • Updates in hormonal emergency contraception.

    abstract::In recent years, there have been many updates in hormonal emergency contraception. Levonorgestrel emergency contraception has been available for several years to prevent pregnancy when used within 72 hours after unprotected intercourse or contraceptive failure, and it was recently approved for nonprescription status f...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.31.9.887

    authors: Shrader SP,Hall LN,Ragucci KR,Rafie S

    更新日期:2011-09-01 00:00:00

  • Management of coronary heart disease risk factors and progression with calcium channel blockers.

    abstract::The death rate from coronary heart disease (CHD) declined by 25% in the United States during 1987-1997, but the actual number of deaths fell by only 9%. Modifiable risk factors for CHD include hypertension, elevated low-density lipoprotein cholesterol, reduced high-density lipoprotein cholesterol, cigarette smoking, a...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.14.195s.34602

    authors: Pieper JA

    更新日期:2001-09-01 00:00:00

  • The use of fluoroquinolones as antiinfective transition-therapy agents in community-acquired pneumonia.

    abstract::The newer quinolone antibiotics, including levofloxacin, moxifloxacin, and gatifloxacin, offer coverage of the likely pathogens in community-acquired pneumonia (CAP) and have been shown to be safe and effective treatments for CAP. Two of these agents, levofloxacin and gatifloxacin, have pharmacokinetic and antibacteri...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.10.100s.34534

    authors: Press RA

    更新日期:2001-07-01 00:00:00

  • Immunoactivation and altered intercellular communication mediate the pathophysiology of spinal cord injury.

    abstract::Evidence and inferences from clinical research, clinical observation, and literature review support an etiologic paradigm for the pathophysiology of spinal cord injury (SCI). According to this paradigm, changes in immunoregulation and in the activation of cytokines or intercellular adhesion molecules (ICAMs) contribut...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.25.2.145.56958

    authors: Segal JL

    更新日期:2005-02-01 00:00:00

  • Diflunisal in the treatment of the pain of osteoarthritis. Summary of clinical studies.

    abstract::In comprehensive clinical studies, diflunisal--a new nonsteroidal antiinflammatory drug with a long duration of action--was shown to be highly effective and generally well tolerated in the short- and long-term treatment of the pain of osteoarthritis. In double-blind comparison studies, diflunisal was comparable in eff...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:

    authors: Umbenhauer ER

    更新日期:1983-03-01 00:00:00

  • Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulations.

    abstract:STUDY OBJECTIVE:To evaluate the toxicity of amphotericin B deoxycholate formulations. DESIGN:In vitro experiment. SETTING:University research center. MATERIAL:Human mononuclear THP-1 cells. INTERVENTION:The human mononuclear cells were exposed in vitro for 2 hours to the following deoxycholate formulations of ampho...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.5.572.32209

    authors: Cleary JD,Rogers PD,Chapman SW

    更新日期:2003-05-01 00:00:00

  • Emerging roles for pharmacists in clinical implementation of pharmacogenomics.

    abstract::Pharmacists are uniquely qualified to play essential roles in the clinical implementation of pharmacogenomics. However, specific responsibilities and resources needed for these roles have not been defined. We describe roles for pharmacists that emerged in the clinical implementation of genotype-guided clopidogrel ther...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1481

    authors: Owusu-Obeng A,Weitzel KW,Hatton RC,Staley BJ,Ashton J,Cooper-Dehoff RM,Johnson JA

    更新日期:2014-10-01 00:00:00

  • High-performance capillary electrophoresis in the pharmaceutical sciences.

    abstract::High-performance capillary electrophoresis (HPCE) is a new separation technique that is applied in the pharmaceutical sciences. Separations by HPCE occur in a narrow-bore capillary under the influence of an applied electrical field. Components of the sample matrix are separated and migrate at different rates based on ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Brunner LJ,DiPiro JT,Feldman S

    更新日期:1995-01-01 00:00:00

  • Amiodarone use in patients with documented allergy to iodine-containing compounds.

    abstract::The popularity of amiodarone has grown due to its effectiveness in converting arrhythmia and its formulation availability. Formulations of the drug also contain iodine; the iodine content is 75 mg in a 200-mg tablet of amiodarone and 18.7 mg/ml in the intravenous solution. Approximately 10% of the iodine content of or...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.25.3.429.61602

    authors: Brouse SD,Phillips SM

    更新日期:2005-03-01 00:00:00